Last A$2.66 AUD
Change Today +0.01 / 0.38%
Volume 50.2M
HSO On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 12:10 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

healthscope ltd (HSO) Snapshot

Open
A$2.65
Previous Close
A$2.65
Day High
A$2.71
Day Low
A$2.62
52 Week High
12/19/14 - A$2.71
52 Week Low
07/28/14 - A$2.09
Market Cap
4.6B
Average Volume 10 Days
11.3M
EPS TTM
A$-0.06
Shares Outstanding
1.7B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTHSCOPE LTD (HSO)

Related News

No related news articles were found.

healthscope ltd (HSO) Related Businessweek News

No Related Businessweek News Found

healthscope ltd (HSO) Details

Healthscope Limited provides private health care services. The company’s Hospitals segment offers medical and surgical services in the fields of intensive care, maternity, cardiac, orthopaedics, urology, oral, gynaecology, endoscopy, vascular, and ear, nose, and throat surgery, as well as provides general, plastic, other specialist and day surgery. This segment also provides treatment for anxiety, depression, schizophrenia, post-traumatic stress, eating disorders, alcohol and drug addiction, and obsessive compulsive disorders; and rehabilitation services for patients with acquired brain injury, musculoskeletal injuries, cardiac and stroke, and pain management. It operates 44 private hospitals with approximately 4,400 beds, including 31 acute hospitals, 7 psychiatric hospitals, and 6 rehabilitation and extended care facilities, as well as operates independent living housing facilities. Its International Pathology segment provides various pathology services primarily under the Labtests, SCL, and Northland brands; and general practitioner, specialist, hospital, and corporate screening services, as well as offers women’s and children’s health services. It operates 13 laboratories in New Zealand; 26 laboratories in Malaysia; and 1 central laboratory in Singapore, as well as manages 1 laboratory in Vietnam. The company’s Australian Pathology segment provides anatomical, biochemistry, haematology, microbiology, and molecular pathology services; and general practice management services, as well as operates one specialist breast diagnostic clinic in Sydney. As of May 19, 2014, it operated 578 collection centers and 69 accredited laboratories; and 46 medical centers and 11 specialist skin cancer clinics. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. Healthscope Limited was founded in 1985 and is based in Melbourne, Australia. Healthscope Limited operates as a subsidiary of Healthscope Group.

Founded in 1985

healthscope ltd (HSO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

healthscope ltd (HSO) Key Developments

Leighton Holdings Limited Appoints Healthscope Limited as the Northern Beaches Hospital Operator

Leighton Holdings' company Leighton Contractors has reached contractual close with Healthscope Limited to design and construct Sydney's new Northern Beaches Hospital. Revenue from the project is approximately $540 million. Healthscope has been appointed as the Northern Beaches Hospital operator having reached contractual close on an agreement with the NSW Government for the design, construction, financing and operation of the hospital. The design includes: a 50-space emergency department, 14 operating theatres and six surgical suites, intensive care and critical care units, a modern inpatient mental health facility. At its peak, the design and construction of this project will provide employment for approximately 700 people. Construction is due to begin in early 2015. The new hospital is set to open in 2018.

Healthscope Limited(ASX:HSO) added to S&P/ASX 200 Index

Healthscope Limited(ASX:HSO) added to S&P/ASX 200 Index

Healthscope Limited(ASX:HSO) added to S&P/ASX 300 Index

Healthscope Limited(ASX:HSO) added to S&P/ASX 300 Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSO:AU A$2.66 AUD +0.01

HSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HSO.
View Industry Companies
 

Industry Analysis

HSO

Industry Average

Valuation HSO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHSCOPE LTD, please visit www.healthscope.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.